Indefinite Delivery Contract 75N93018D00013
Award Date
9/12/18
Last Date to Order
9/11/28
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Battelle Memorial Institute
Ultimate Awardee
Not listed
NAICS Category
541713 - Research and Development in Nanotechnology
Federal Contract Vehicle
Pricing Type
Cost Plus Fixed Fee
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $102.5 million Indefinite Delivery Contract to Battelle Memorial Institute to provide research, development, testing, and evaluation services for vaccines and other biologics for infectious diseases. Under this contract, Battelle has been issued numerous cost-plus-fixed-fee and cost-plus-award-fee delivery orders to support NIAID's programs....
This single-award Indefinite Delivery Contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Battelle Memorial Institute, a non-profit organization and manufacturer of goods, to provide pre-clinical models of infectious diseases. The $146.3 million, 7-year contract has a completion date of July 14, 2031 and was awarded on July 15, 2024. The contract aims to develop and employ animal and...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an indefinite delivery indefinite quantity contract to Battelle Memorial Institute to provide comprehensive and rapid response services in support of research programs. With a potential value of $545 million and a period of performance through August 2028, this multiple award contract vehicle enables NIH to obtain a wide range of research support services on an as-needed basis. A $2 million firm fixed...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a multiple-award Indefinite Delivery Contract (IDC) worth up to $80 million to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. Under this IDC, IAVI provides a range of research, development, manufacturing, and advocacy services to advance the creation and delivery of vaccines and antibodies for infectious diseases such as HIV,...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract valued up to $146,300,000 to Southern Research Institute, a non-profit research organization, to develop and employ animal and animal replacement models of infectious diseases. The contract will support screening, product evaluation, and eventual clinical evaluation of vaccines, therapeutics, and...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Lovelace Biomedical Research Institute on September 1, 2021 with a potential value of $545,452,906. Under the terms of the contract, Lovelace Biomedical Research Institute will provide a broad range of services to support biomedical research conducted by NIAID, including clinical trials, manufacturing and controls, nonclinical animal studies, analytics,...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to PPD Development LP with a potential value of $545,452,906 to provide comprehensive and rapid response capabilities for research programs through September 2028. Task orders issued against the contract include over $132 million for clinical trial management support services relating to COVID-19, as well as orders valued at $2.33 million, $2 million, and $82.5...
The National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to FHI Clinical Inc. to provide comprehensive and rapid response research programs. The contract has a potential value of $545,452,906 over a seven-year ordering period through August 2028. Two task orders have been issued against it to date, one for $332,178 and another for $2,000. Under the contract, FHI Clinical Inc. will support the NIAID's mission to conduct biomedical research on infectious,...
The federal contract IDV award, with an ID of 75N93024D00022, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). This single-award Indefinite Delivery Contract, potentially valued up to $146,300,000, is for pre-clinical models of infectious diseases under task areas A, B, and C. The prime contractor, Texas Biomedical Research Institute, will provide a range of services including developing...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded an Indefinite Delivery Contract (IDC) to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization, to provide a range of research, development, manufacturing, and advocacy services to advance the creation and delivery of vaccines and antibodies for infectious diseases. The contract, valued at up to $98.6 million, has a period of performance...